Literature DB >> 23656388

First trimester maternal serum pregnancy-associated plasma protein-A is a predictive factor for early preterm delivery in normotensive pregnancies.

Banu Dane1, Cem Dane, Gonca Batmaz, Seda Ates, Ramazan Dansuk.   

Abstract

In this study, we investigated whether the concentrations of pregnancy-associated plasma protein-A (PAPP-A) or free β-hCG (fβhCG) in the first trimester can identify women at increased risk of subsequent preterm delivery in the absence of hypertensive disorders. Preterm and early preterm deliveries are defined as those deliveries before completing 37 and 34 weeks, respectively. A total of 868 women were enrolled into this study. According to the level of the markers, the patients were evaluated in three groups: 1 - maternal serum level ≤ 5 th percentile, 2 - between 5th and 95th percentiles, 3 - ≥ 95 th percentile. In the group of patients with a PAPP-A level ≤ 5 th percentile [≤ 0.35 multiples of the median (MoM)], mean gestational age (GA) at delivery, mean birth weight and the number of the cases with early preterm delivery were significantly lower than the others. Mean level of PAPP-A was significantly lower in cases with early preterm than term deliveries (0.58 ± 0.32 versus 1.09 ± 0.69; p = 0.01). Maternal serum level of fβhCG did not show significant difference between these groups (0.84 ± 0.45 versus 1.17 ± 0.77; p = 0.15). Low levels of maternal serum PAPP-A (≤ 0.35 MoM) (Odds ratio = 7; 95% confidence interval 1.8-27.7; p = 0.0048) significantly predicted early preterm delivery in normotensive pregnancies. Women with low levels of PAPP-A at first trimester have a higher risk of early preterm delivery even in the absence of hypertensive disorders.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23656388     DOI: 10.3109/09513590.2013.788626

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  5 in total

Review 1.  Hypertension in Pregnancy: Defining Blood Pressure Goals and the Value of Biomarkers for Preeclampsia.

Authors:  Pitchaphon Nissaisorakarn; Sairah Sharif; Belinda Jim
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

2.  Maternal characteristics and mid-pregnancy serum biomarkers as risk factors for subtypes of preterm birth.

Authors:  L L Jelliffe-Pawlowski; R J Baer; Y J Blumenfeld; K K Ryckman; H M O'Brodovich; J B Gould; M L Druzin; Y Y El-Sayed; D J Lyell; D K Stevenson; G M Shaw; R J Currier
Journal:  BJOG       Date:  2015-06-26       Impact factor: 6.531

3.  Maternal Serum Aneuploidy Screen and Adverse Pregnancy Outcomes.

Authors:  Koumudi Godbole; Aparna Kulkarni; Asawari Kanade; Shilpa Kulkarni; Girish Godbole; Anuradha Wakankar
Journal:  J Obstet Gynaecol India       Date:  2016-03-11

4.  The Relationship of Pregnancy-Associated Plasma Protein A and Human Chorionic Gonadotropin with Adverse Pregnancy Outcomes: A Prospective Study.

Authors:  Hamideh Pakniat; Atieh Bahman; Iman Ansari
Journal:  J Obstet Gynaecol India       Date:  2019-04-11

5.  Prediction of Pregnancy Complications With Maternal Biochemical Markers Used in Down Syndrome Screening.

Authors:  Savas Ozdemir; Orhan Sahin; Zuat Acar; Gozde Zeynep Demir; Ece Ermin; Alev Aydin
Journal:  Cureus       Date:  2022-03-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.